S. Verma

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Gabriel N. Hortobágyi, Salomon M. Stemmer, H. A. Burris et al. · Annals of Oncology · 2018 · 868 citations · Full text

Medicine, Oncology, Pharmacology +17

Cardiac Management during Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group

John R. Mackey, M. Clemons, Marc André Côté et al. · Current Oncology · 2008 · 143 citations · Full text

Medicine, Cardiology, Oncology +17

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer

Mario Cappelli, Linda Surh, Lauren Humphreys et al. · Clinical Genetics · 1999 · 116 citations · Full text

Life Sciences, Genetics, Oncology +15

Abstract S1-03: Primary results from BETH, a phase 3 controlled study of adjuvant chemotherapy and trastuzumab ± bevacizumab in patients with HER2-positive, node-positive or high risk node-negative breast cancer

DJ Slamon, SM Swain, Marc Buyse et al. · Cancer Research · 2013 · 92 citations

Medicine, Oncology, Pharmacology +17

Living with the BRCA genetic mutation: An uncertain conclusion to an unending process

Julia DiMillo, André Samson, Anne Thériault et al. · Psychology Health & Medicine · 2012 · 49 citations

Social Sciences, Oncology, Feminist Theory +16